APA (7th ed.) Citation

Isayev, O., Rausch, V., Bauer, N., Liu, L., Fan, P., Zhang, Y., . . . Herr, I. (2014). Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. OncoTarget, 5(13), .

Chicago Style (17th ed.) Citation

Isayev, Orkhan, et al. "Inhibition of Glucose Turnover by 3-bromopyruvate Counteracts Pancreatic Cancer Stem Cell Features and Sensitizes Cells to Gemcitabine." OncoTarget 5, no. 13 (2014).

MLA (9th ed.) Citation

Isayev, Orkhan, et al. "Inhibition of Glucose Turnover by 3-bromopyruvate Counteracts Pancreatic Cancer Stem Cell Features and Sensitizes Cells to Gemcitabine." OncoTarget, vol. 5, no. 13, 2014.